CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Grant or award Chief Medical Officer acquired 12,500 shares (grant or award)
- 8-K Event Acquisition or sale completed
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 459 shares at $26.68 ($12,246)
- 4 Gift 10% owner gave 1,232,434 shares (gift)
- 4 Planned sale SVP, Finance and Treasurer sold 467 shares at $24.53 ($11,456)
- 4 Planned sale Chief Legal Officer sold 373 shares at $24.53 ($9,150)
- 4 Planned sale CEO sold 50,000 shares at an average $24.57 ($1,228,323)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 48,374 shares at $20.50 ($991,667)
- 4 Planned sale Chief Medical Officer sold 1,250 shares at an average $19.17 ($23,962)
- 8-K Event Unregistered share sale
- 4 Derivatives Options or other derivatives
Page 5 of 26 · 514 filings